Coronary artery calcium (CAC) score? (further testing beyond basic labs) Above 0
cac-positiveFewer than 5 people have reached this rule so farTreat now; the score sets the goal — any calcium → LDL <100, ≥100 → <70, ≥300 → <55 optional
No clinician has signed off this rule yet. It reflects our reading of the guidelines cited below, which has not been independently checked.
Word for word, as generated for the example person below. Figures in the text are theirs.
Your CAC score of 140 supports starting lipid-lowering therapy now, aiming for LDL-C below 70 mg/dL (and non-HDL-C below 100).
Expert guidelinesOfficial guidelines recommend it, based on trials plus expert judgment.
Any coronary calcium at borderline or intermediate risk supports treating rather than waiting, and the score itself sharpens the target: any calcium supports a goal of 100, and 140 being at or above 100 supports 70. One thing to know before any repeat scan: a statin that is working reliably raises this number, because the score weights density and treatment makes plaque denser. A higher score later is not a reason to stop the statin.
ACC/AHA (US)
Graded for adults at intermediate risk and selected adults at borderline risk: any score above 0 supports starting treatment, particularly 100 or more.
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Recommendation behind this rule · class and level read from the guideline tables on 2026-09-30
An LDL-C goal below 70 (non-HDL-C below 100) at a score of 100 to 299
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Graded separately within the same recommendation · class and level read from the guideline tables on 2026-09-30
ESC (Europe)
Calcium score as a risk modifier near a treatment threshold. The ESC sorts risk with SCORE2, not the PREVENT equations used here, so the tiers line up only roughly.
2025 ESC/EAS focused update on dyslipidaemias · Recommendation tables · class and level read from the guideline tables on 2026-09-30
2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia · Class 1 · Level B-NR
“Borderline risk, calcium found, hs-CRP raised” — an illustrative profile, not a real user.
Asked after: Chronic kidney disease, age 40–75, HIV, age 40–75, 10-year risk 5% to under 10%, 10-year risk 3% to under 5%, Low 10-year risk, high lifetime risk, Low risk with a major risk enhancer
Cited by the recommendations above.
A trial that could change this, still running or reported too recently to be settled.
For practising clinicians. Endorse it, propose a change, or dispute it. We verify every reviewer before a review is shown, and a review stays attached to the version of the rule you saw — if the rule changes, the page says so. You'll be asked to declare any relevant interests; they're shown with your review.
Log in or create an account to submit a review. An account is how we tie a review to a person we can verify.
Runs in lib/engine/lipidPathway.ts as cac-positive.